Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29ClN4O2S |
InChIKeyIVDUVEGCMXCMSO-FQEVSTJZSA-N |
CAS Registry1404456-53-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | GB | 10 Jan 2024 |